Dublin, Dec. 15, 2016 -- Research and Markets has announced the addition of the "Prefilled Syringes in 2017 & Beyond" report to their offering.
The administration of therapeutic drugs via injection is an indispensable delivery method for numerous drugs critical to patient health and well-being. Now this segment is evolving in response to changing patient populations, new classes of powerful therapeutic drugs and healthcare administration initiatives. Population demographics and efforts by managed care providers to control healthcare costs are driving the growth in drug self-administration, particularly for chronic conditions, introducing a new class of naïve users to parenteral drug delivery.
For Fill-and-Finish contractors, market proximity is an important competitive factor. As the use of prefilled syringes continues to grow, the issue of prefilled syringe safety has received increased attention, with both integrated prefillable safety syringes and safety solutions designed to accommodate existing prefillable syringes advancing commercially. This report analyzes eleven important prefilled syringe therapeutic segments and examines key regulatory, economic and competitive factors that represent potential barriers to commercial success.
What You Will Learn
- What drugs are supplied in prefilled syringes, what are the drug + device specifics, and who markets them?
- Who are the branded prefilled syringe suppliers, their manufacturing infrastructure and locations, their capabilities?
- What are the major factors driving prefilled syringe demand?
- What is the importance of industry collaborations on commercial success and what are the specifics of these partnerships and alliances
- What are the essential design factors, material selection issues, technologies and market development issues for prefilled injectable drug products?
- What are prefilled device categories that compete with prefilled syringes and what is their market share?
- What are the significant economic, technology, and regulatory factors affecting the market for prefilled syringes?
Key Topics Covered:
1. Executive Summary
2. Prefilled Syringes in 2017 and Beyond
- The Prefilled Device Landscape
- Prefilled Syringe Market Drivers
- Innovation in Prefillable Device Designs
- Evolution of the Fill/Finish Ecosystem
- Incidence of Chronic Conditions
- NMEs and the Treatment of Refractory Diseases
- Therapeutic Demand Drivers for PFS
- Commercial Landscape - Competition & Collaboration
3. Prefilled Syringes - Design Factors
- Drug Stability and Shelf Life
- Material Selection Issues
- Point-of-Use Reconstitution
- Caregiver Safety
- Human Engineering/Ergonomics
4. Prefilled Syringes - Commercial Devices
- Prefillable Therapeutic Injectables
- Glass Prefillable Syringes
- Plastic Prefillable Syringes
- Ready-to-Fill Safety Syringes
- Specialty Prefillable Syringes
- Flush Syringes
- Diluent Syringes
- Imaging Agent Syringes
5. Prefilled Syringe Market Segments - Market Data & Forecasts
- Anaphylaxis
- Anticoagulants
- Autoimmune Diseases
- Emergency Medicine
- Hepatitis
- Hematopoietics and Related ESPs
- Metabolic Diseases
- Neurology
- Reproductive Health
- Vaccines
6. Market Factors
- Regulatory Issues
- Device Branding
- Patient Compliance and Ease of Use
- Healthcare Economics
- PFS Sector Partnerships and Alliances
7. Company Profiles
For more information about this report visit http://www.researchandmarkets.com/research/xp66dx/prefilled
CONTACT: Research and Markets
Laura Wood, Senior Manager
[email protected]
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716
Related Topics: Infusions and Injectables , Needles and Syringes


LG Energy Solution Shares Slide After Ford Cancels EV Battery Supply Deal
Bridgewater Associates Plans Major Employee Ownership Expansion in Milestone Year
Oracle Stock Slides After Blue Owl Exit Report, Company Says Michigan Data Center Talks Remain on Track
Boeing Seeks FAA Emissions Waiver to Continue 777F Freighter Sales Amid Strong Cargo Demand
Union-Aligned Investors Question Amazon, Walmart and Alphabet on Trump Immigration Policies
Harris Associates Open to Revised Paramount Skydance Bid for Warner Bros Discovery
FedEx Beats Q2 Earnings Expectations, Raises Full-Year Outlook Despite Stock Dip
FDA Fast-Tracks Approval of Altria’s on! PLUS Nicotine Pouches Under New Pilot Program
Oracle Stock Surges After Hours on TikTok Deal Optimism and OpenAI Fundraising Buzz
Roche CEO Warns US Drug Price Deals Could Raise Costs of New Medicines in Switzerland
U.S. Lawmakers Urge Pentagon to Blacklist More Chinese Tech Firms Over Military Ties
7-Eleven CEO Joe DePinto to Retire After Two Decades at the Helm
Google and Apple Warn U.S. Visa Holders to Avoid International Travel Amid Lengthy Embassy Delays
Instacart Stock Drops After FTC Probes AI-Based Price Discrimination Claims
Toyota to Sell U.S.-Made Camry, Highlander, and Tundra in Japan From 2026 to Ease Trade Tensions
Elon Musk Wins Reinstatement of Historic Tesla Pay Package After Delaware Supreme Court Ruling
ANZ New CEO Forgoes Bonus After Shareholders Reject Executive Pay Report 



